Patent Yard Sign in
Expired Canadian patentCanada

Inhibitors of proteasomal activity for stimulating bone and hair growth

CA 2337988 C · Owner: Garrett, I. Ross · Inventors: Mundy, Gregory R.; Rossini, G.; Garrett, I. Ross

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds that inhibit the activity of NF-B or inhibit the activity of the proteasome or both promote bone formation and hair growth and are thus useful in treating osteoporosis, bone fracture or deficiency primary or secondary , hyperparathyroidism periodontal disease or defect, metastatic bone disease osteolytic bone disease, post-plastic surgery post-prosthetic joint surgery, and post-dental implantation; they also stimulate the production of hair follicles and are thus useful in stimulating hair growth including hair , density, in subject where this is desirable.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 9, 1999 and granted April 26, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 9, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 9, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 9, 1999
GrantedApril 26, 2011
Term endedJuly 9, 2019
Patent numberCA 2337988 C
Classification (IPC)A61K38/06 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedJuly 9, 1999Patent grantedApril 26, 2011Term endedJuly 9, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.